NextCure, Inc. (NXTC)
Largest Insider Buys in Sector
NXTC Stock Price History Chart
NXTC Stock Performance
About NextCure, Inc.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Insider Activity of NextCure, Inc.
Over the last 12 months, insiders at NextCure, Inc. have bought $0 and sold $0 worth of NextCure, Inc. stock.
On average, over the past 5 years, insiders at NextCure, Inc. have bought $5.51M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 150,000 shares for transaction amount of $5.51M was made by Sofinnova Venture Partners IX, L.P. (10 percent owner) on 2019‑11‑15.
List of Insider Buy and Sell Transactions, NextCure, Inc.
| 2019-11-15 | Sofinnova Venture Partners IX, L.P. | 10 percent owner | 150,000 0.9742% | $36.75 | $5.51M | -7.91% | ||
| 2019-05-13 | ORBIMED ADVISORS LLC | 700,000 4.0096% | $15.00 | $10.5M | +82.16% | |||
| 2019-05-13 | Khuong Chau Quang | director | 350,000 2.0048% | $15.00 | $5.25M | +82.16% | ||
| 2019-05-13 | Sofinnova Venture Partners IX, L.P. | 10 percent owner | 400,000 2.2912% | $15.00 | $6M | +82.16% | ||
| 2019-05-13 | SHANNON TIMOTHY M | director | 50,000 0.2864% | $15.00 | $750,000 | +82.16% | ||
| 2019-05-13 | CANAAN X L.P. | 10 percent owner | 50,000 0.2864% | $15.00 | $750,000 | +82.16% | ||
| 2019-05-13 | Xu Stella | director | 125,000 0.716% | $15.00 | $1.88M | +82.16% |
Insider Historical Profitability
| Khuong Chau Quang | director | 2711013 9.7158% | $1.60 | 1 | 0 | |
| ORBIMED ADVISORS LLC | 2711013 9.7158% | $1.60 | 1 | 0 | ||
| Sofinnova Venture Partners IX, L.P. | 10 percent owner | 2671856 9.5755% | $1.60 | 2 | 0 | <0.0001% |
| CANAAN X L.P. | 10 percent owner | 2254442 8.0796% | $1.60 | 1 | 0 | |
| SHANNON TIMOTHY M | director | 2254442 8.0796% | $1.60 | 1 | 0 | |
| Xu Stella | director | 1103570 3.955% | $1.60 | 1 | 0 |
Institutional Investor Ownership
| Sofinnova | $5.96M | 9.55 | 2.67M | 0% | +$0 | 0.01 | |
| Logos Global Management Lp | $4.29M | 6.88 | 1.93M | New | +$4.29M | 0.46 | |
| Affinity Asset Advisors | $3.03M | 4.86 | 1.36M | New | +$3.03M | 0.54 | |
| OrbiMed | $2.54M | 4.08 | 1.14M | -57.91% | -$3.5M | 0.05 | |
| Millennium Management LLC | $2.53M | 4.05 | 1.13M | -0.55% | -$14,073.53 | <0.01 | |
| The Vanguard Group | $2.2M | 3.53 | 987,324 | +9.26% | +$186,651.04 | <0.0001 | |
| BlackRock | $1.7M | 2.72 | 761,334 | -14.47% | -$287,152.67 | <0.0001 | |
| Long Focus Capital Management Llc | $1.24M | 1.99 | 556,105 | 0% | +$0 | 0.14 | |
| Acadian Asset Management | $1.09M | 1.75 | 488,440 | 0% | +$0 | <0.01 | |
| Assenagon Asset Management S.A. | $951,579.00 | 1.53 | 426,717 | New | +$951,579.00 | <0.01 | |
| Morgan Stanley | $897,035.00 | 1.44 | 402,258 | +397.67% | +$716,788.63 | <0.0001 | |
| Renaissance Technologies | $893,000.00 | 1.43 | 400,400 | +36.51% | +$238,828.43 | <0.01 | |
| Schonfeld Group | $876,925.00 | 1.41 | 393,240 | New | +$876,925.00 | 0.01 | |
| Federated Hermes | $730,113.00 | 1.17 | 327,405 | -0.14% | -$985.66 | <0.01 | |
| Acuitas Investments, LLC | $717,295.00 | 1.15 | 321,657 | -13.72% | -$114,046.64 | 0.38 | |
| Bml Capital Management Llc | $683,417.00 | 1.1 | 306,465 | 0% | +$0 | 0.52 | |
| Cardiff Park Advisors | $584,260.00 | 0.94 | 262,000 | New | +$584,260.00 | 0.08 | |
| Citadel Advisors LLC | $547,411.00 | 0.88 | 245,476 | -34.69% | -$290,733.77 | <0.0001 | |
| Hudson Bay Capital Management LP | $454,474.00 | 0.73 | 203,800 | New | +$454,474.00 | 0.01 | |
| Geode Capital Management | $389,715.00 | 0.63 | 174,707 | 0% | +$0 | <0.0001 | |
| Macquarie Group | $335,000.00 | 0.54 | 150,000 | 0% | +$0 | <0.0001 | |
| Tang Capital Management, LLC | $322,280.00 | 0.52 | 144,520 | -69.11% | -$721,187.35 | <0.01 | |
| Sio Capital Management LLC | $289,900.00 | 0.47 | 130,000 | 0% | +$0 | 0.1 | |
| Dimensional Fund Advisors | $191,452.00 | 0.31 | 85,853 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $157,438.00 | 0.25 | 70,600 | -25.37% | -$53,520.00 | <0.01 | |
| Barclays | $150,000.00 | 0.24 | 67,548 | 0% | +$0 | <0.0001 | |
| Tealwood Asset Management | $129,918.00 | 0.21 | 58,259 | 0% | +$0 | 0.03 | |
| Two Sigma Advisers LP | $128,671.00 | 0.21 | 57,700 | 0% | +$0 | <0.0001 | |
| State Street | $127,315.00 | 0.2 | 57,092 | 0% | +$0 | <0.0001 | |
| IEQ Capital | $83,273.00 | 0.13 | 37,342 | 0% | +$0 | <0.01 | |
| Northern Trust | $75,254.00 | 0.12 | 33,746 | +2.25% | +$1,654.67 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $60,210.00 | 0.1 | 27,000 | +79.62% | +$26,688.64 | <0.0001 | |
| Xtx Topco Ltd | $43,886.00 | 0.07 | 19,680 | +14.23% | +$5,467.91 | <0.01 | |
| HSBC | $38,719.00 | 0.06 | 17,363 | 0% | +$0 | <0.0001 | |
| UBS | $24,113.00 | 0.04 | 10,813 | +72.54% | +$10,137.58 | <0.0001 | |
| HarbourVest Partners | $22,398.00 | 0.04 | 10,044 | 0% | +$0 | 0.01 | |
| Charles Schwab | $22,300.00 | 0.04 | 10,000 | 0% | +$0 | <0.0001 | |
| Bank of America | $6,079.00 | 0.01 | 2,726 | +10,804% | +$6,023.25 | <0.0001 | |
| Wells Fargo | $4,810.00 | 0.01 | 2,157 | +1,291.61% | +$4,464.36 | <0.0001 | |
| Tower Research Capital | $5,071.00 | 0.01 | 2,274 | -71.89% | -$12,971.86 | <0.0001 | |
| JPMorgan Chase | $1,791.00 | <0.01 | 803 | -46.65% | -$1,565.73 | <0.0001 | |
| RhumbLine Advisers | $1,567.00 | <0.01 | 703 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 17 | -93.58% | -$0 | <0.0001 | |
| Qube Research & Technologies | $107.00 | <0.01 | 48 | 0% | +$0 | <0.0001 |